Severe course of leptospirosis: A case report

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

This study describes a clinical case of severe leptospirosis. Patient K., was admitted to the neurosurgical department on November 26, 2023, with a diagnosis of “Closed craniocerebral injury dated 22.11.2023. Severe brain injury. Linear fracture of the occipital bone. Eyelid hematoma. An abrasion of the upper eyelid on the right.” On November 29, 2023, an objective examination drew attention to an increase in body temperature to 39.5°C, subictericity of the sclera and skin, and conjunctival injections. Hemorrhagic rash appeared on the skin of the trunk and limbs. The hemodynamics was unstable, with episodes of arterial hypotension. Laboratory examination revealed mild anemia, signs of hepatic–renal insufficiency, hyperbilirubinemia, and increased concentrations of creatine phosphokinase, C-reactive protein, and procalcitonin. Fluctuations in hepatic–renal insufficiency and levels of creatine phosphokinase and procalcitonin increased. In addition, the differential diagnostic search aimed at identifying the following infectious diseases: hemorrhagic fever with renal syndrome, leptospirosis, malaria, and viral hepatitis. IgM to Leptospira interrogans were detected (December 11, 2023). The patient received antibacterial therapy, extracorporeal detoxification, artificial ventilation, infusion therapy, and correction of the hemostasis system. With the complex treatment, the patient’s condition stabilized, and the patient was discharged from the hospital on the 61st day with restoration of health.

全文:

受限制的访问

作者简介

Dmitriy Efremov

The National Medical Research Center of High Medical Technologies — the Central Military Clinical Hospital of A.A. Vishnevsky

编辑信件的主要联系方式.
Email: Efremov-d24@mail.ru
ORCID iD: 0000-0001-7889-6052
SPIN 代码: 7115-2713

MD, Cand. Sci. (Medicine)

俄罗斯联邦, Krasnogorsk

Ainur Khuramshin

The National Medical Research Center of High Medical Technologies — the Central Military Clinical Hospital of A.A. Vishnevsky

Email: ainur83@inbox.ru
ORCID iD: 0009-0006-7956-4694
SPIN 代码: 6195-3308
俄罗斯联邦, Krasnogorsk

Vladimir Beloborodov

Russian Medical Academy of Continuous Professional Education

Email: belvb1070@mail.ru
ORCID iD: 0000-0002-0544-4167
SPIN 代码: 4233-2046

MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, Moscow

参考

  1. Gorodin VN, Moysova DL, Bakhtina VA, Zotov SV. Trends of Contemporary Leptospirosis (Review of Literature). Epidemiology and Infectious Diseases. 2018;23(2):93–100. (In Russ). doi: 10.18821/1560-9529-2018-23-2-93-100
  2. Trankvilevsky DV, Kiseleva EYu, Korzun VM, et al. Epizootiological and Epidemiological Situation on Leptospirosis in the Russian Federation over the Period of 2013–2022 and the Forecast for 2023. Problems of Particularly Dangerous Infections. 2023;(3):43–50. (In Russ). doi: 10.21055/0370-1069-2023-3-43-50
  3. Breneva NV, Balakhonov SV, Allenov AV, et al. Clinical and epidemiological features of leptospirosis in Siberia and the Far East. Infectious Diseases: News, Opinions, Training. 2018;7(3):62–67. (In Russ). doi: 10.24411/2305-3496-2018-13009
  4. Nechaev VV, Yarovayа II, Gorbunova IV, et al. Epidemiological, ecological and clinico-laboratory characteristics of hemorrhagic fever with renal syndrome in Saint-Petersburg and suburb. Journal Infectology. 2021;13(2):126–134. (In Russ). doi: 10.22625/2072-6732-2021-13-2-126-134
  5. Fesenko NV, Abdubalieva AA. Clinical case of unicteric form of leptospirosis. Vestnik of KSMA named after I.K. Akhunbayev. 2018(3):62–64. (In Russ). EDN: MAPCAP.
  6. Costa F, Hagan JE, Calcagno J, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Neglected Tropical Diseases. 2015;9(9):e0003898. doi: 10.1371/journal.pntd.0003898
  7. Goarant C. Leptospirosis: risk factors and management challenges in developing countries. Research and Reports in Tropical Medicine. 2016;7:49–62. doi: 10.2147/RRTM.S102543
  8. Verma V, Goyal M, Kala D, et al. Recent advances in the diagnosis of leptospirosis. Frontiers in Bioscience-Landmark. 2020;25(9): 1655–1681. doi: 10.2741/4872
  9. Petrova OA, Lyubimova NE, Arsent’eva NA., et al. The content of some cytokines in the serum of patients with leptospirosis. Medical Immunology (Russia). 2017;19(S):133. (In Russ).
  10. Nikulina MA, Granitov VM, Tanashkin SF, Volchkova EV, Nemilostiva EA. Problems finding imported case leptospirosis (clinical observation). Epidemiology and Infectious Diseases. 2017;22(1):36–41. (In Russ). doi: 10.17816/EID40969
  11. Hoenigl M, Wallner C, Allerberger F, et al. Autochthonous leptospirosis in South-East Austria, 2004–2012. PLoS One. 2014;9(1):e85974. doi: 10.1371/journal.pone.0085974
  12. Gulati S, Gulati A. Pulmonary manifestations of leptospirosis. Lung India. 2012;29(4):347–353. doi: 10.4103/0970-2113.102822
  13. Ludwig B, Zotzmann V, Bode C, Staudacher DL, Zschiedrich S. Lethal pulmonary hemorrhage syndrome due to Leptospira infection transmitted by pet rat. IDCases. 2017;8:84–86. doi: 10.1016/j.idcr.2017.04.016
  14. Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database of Systematic Reviews. 2012;(2):CD008264. doi: 10.1002/14651858.CD008264.pub2
  15. Krasavtsev EL, Mаiseenko VI, Kozel OA, Kuchun EA. A case of combined course of leptospirosis and coronavirus infection COVID-19. Journal Infectology. 2022;14(4):109–113. (In Russ). doi: 10.22625/2072-6732-2022-14-4-109-113
  16. Lebedev VV, Avdeeva MG, Gorodin VN, et al. Leptospirosis in adults. Clinical recommendations. Moscow: NNOI; 2014. (In Russ).
  17. ILS-WHO. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Malta: WHO; 2003. 109 p.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eco-vector, 2024

许可 URL: https://eco-vector.com/en/for_authors.php#07

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80652 от 15.03.2021
. Учредитель ООО "Эко-Вектор Ай-Пи" (ОГРН 1157847215338).